American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA

Journal of Neuro-Oncology

Volumn 99, Issue 2, 2010, Pages 297-306

  Yang, Isaac ^a   Liau, Linda M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Cancer; Genomics; Glioblastoma; Glioma

Indexed keywords

2 HYDROXYGLUTARIC ACID; ANTINEOPLASTIC AGENT; BETA CATENIN; CANCER VACCINE; CARMUSTINE; CD133 ANTIGEN; CELL PROTEIN; CILENGITIDE; DASATNIB; ERLOTINIB; GEFITINIB; GLYCOPROTEIN GP 130; IMIQUIMOD; INTEGRIN; ISOCITRATE DEHYDROGENASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN IDH1; PROTEIN NF1; PROTEIN P53; PROTEIN TRIM3; PROTEIN YKL40; RAS PROTEIN; SMALL INTERFERING RNA; STAT PROTEIN; TEMOZOLOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

BRAIN CANCER; CANCER GENETICS; CANCER RESEARCH; CARCINOGENESIS; CHILDHOOD CANCER; CONFERENCE PAPER; DENDRITIC CELL; DEVELOPMENTAL BIOLOGY; DIAGNOSTIC IMAGING; DISEASE MODEL; DRUG TARGETING; ENZYME PHOSPHORYLATION; EXPERIMENTAL ANIMAL; GLIOBLASTOMA; GLIOMA; HUMAN; MEDICAL SOCIETY; MEDULLOBLASTOMA; MOLECULAR THERAPY; NONHUMAN;

ANTINEOPLASTIC AGENTS; BIOMEDICAL RESEARCH; BRAIN NEOPLASMS; HUMANS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION;

EID: 77956062451     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0332-4     Document Type: Conference Paper

References (37)

1. N Sanai Z Mirzadeh MS Berger 2008 Functional outcome after language mapping for glioma resection N Engl J Med 358 1 18 27 10.1056/NEJMoa067819 1:CAS:528:DC%2BD1cXitl2gsg%3D%3D 18172171
2. JS Smith EF Chang KR Lamborn, et al. 2008 Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas J Clin Oncol 26 8 1338 1345 10.1200/JCO.2007.13.9337 18323558
3. RK Thomas AC Baker RM Debiasi, et al. 2007 High-throughput oncogene mutation profiling in human cancer Nat Genet 39 3 347 351 10.1038/ng1975 1:CAS:528:DC%2BD2sXitVOktrs%3D 17293865
4. RC Bailey GA Kwong CG Radu, et al. 2007 DNA-encoded antibody libraries: a unified platform for multiplexed cell sorting and detection of genes and proteins J Am Chem Soc 129 7 1959 1967 10.1021/ja065930i 1:CAS:528: DC%2BD2sXhtlemsb8%3D 17260987
5. MJ van den Bent AA Brandes R Rampling, et al. 2009 Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034 J Clin Oncol 27 8 1268 1274 10.1200/JCO.2008.17.5984 19204207
6. TF Cloughesy K Yoshimoto P Nghiemphu, et al. 2008 Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma PLoS Med 5 1 e8 10.1371/journal.pmed.0050008 18215105
7. KL Ligon E Huillard S Mehta, et al. 2007 Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma Neuron 53 4 503 517 10.1016/j.neuron.2007.01.009 1:CAS:528:DC%2BD2sXis1altLk%3D 17296553
8. T Li H Wen C Brayton, et al. 2007 Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase J Biol Chem 282 44 32264 32273 10.1074/jbc.M703649200 1:CAS:528: DC%2BD2sXht1Wls73P 17827153
9. L Ridley R Rahman MA Brundler, et al. 2008 Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma Neuro Oncol 10 5 675 689 10.1215/15228517-2008-036 1:CAS:528:DC%2BD1cXht1Gqsr%2FK 18701711
10. DH Gutmann 2008 Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma J Child Neurol 23 10 1186 1194 10.1177/ 0883073808321061 18952585
11. KV Lu S Zhu A Cvrljevic, et al. 2009 Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients Cancer Res 69 17 6889 6898 10.1158/0008-5472.CAN-09-0347 1:CAS:528: DC%2BD1MXhtVOmtL%2FL 19690143
12. T Reya SJ Morrison MF Clarke, et al. 2001 Stem cells, cancer, and cancer stem cells Nature 414 6859 105 111 10.1038/35102167 1:CAS:528: DC%2BD3MXot1ahs7c%3D 11689955
13. JL Boulay U Stiefel E Taylor, et al. 2009 Loss of heterozygosity of TRIM3 in malignant gliomas BMC Cancer 9 71 10.1186/1471-2407-9-71 19250537
14. J Betschinger K Mechtler JA Knoblich 2006 Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells Cell 124 6 1241 1253 10.1016/j.cell.2006.01.038 1:CAS:528:DC%2BD28Xjt1Khs78%3D 16564014
15. AM Bleau D Hambardzumyan T Ozawa, et al. 2009 PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells Cell Stem Cell 4 3 226 235 10.1016/j.stem.2009.01.007 1:CAS:528:DC%2BD1MXjvVSqsLg%3D 19265662
16. S Alcantara Llaguno J Chen CH Kwon, et al. 2009 Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model Cancer Cell 15 1 45 56 10.1016/j.ccr.2008.12.006 19111880
17. T Marumoto A Tashiro D Friedmann-Morvinski, et al. 2009 Development of a novel mouse glioma model using lentiviral vectors Nat Med 15 1 110 116 10.1038/nm.1863 1:CAS:528:DC%2BD1MXhtVOqtg%3D%3D 19122659
18. RD Read WK Cavenee FB Furnari, et al. 2009 A drosophila model for EGFR-Ras and PI3K-dependent human glioma PLoS Genet 5 2 e1000374 10.1371/journal.pgen.1000374 19214224
19. R McLendon A Friedman D Bigner, et al. 2008 Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 7216 1061 1068 10.1038/nature07385 1:CAS:528:DC%2BD1cXht1yju77J
20. HS Phillips S Kharbanda R Chen, et al. 2006 Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis Cancer Cell 9 3 157 173 10.1016/j.ccr.2006.02.019 1:CAS:528:DC%2BD28XivFWjtL4%3D 16530701
21. JC Lee I Vivanco R Beroukhim, et al. 2006 Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain PLoS Med 3 12 e485 10.1371/journal.pmed.0030485 17177598
22. C Li R Beroukhim BA Weir, et al. 2008 Major copy proportion analysis of tumor samples using SNP arrays BMC Bioinformatics 9 204 10.1186/1471-2105-9-204 18426588
23. JJ Faith B Hayete JT Thaden, et al. 2007 Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles PLoS Biol 5 1 e8 10.1371/journal.pbio.0050008 17214507
24. LM Liau KL Black NA Martin, et al. 2000 Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case report Neurosurg Focus 9 6 e8 10.3171/foc.2000.9.6.9 1:STN:280:DC%2BD28vgtVahtQ%3D%3D 16817691
25. LM Liau RM Prins SM Kiertscher, et al. 2005 Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment Clin Cancer Res 11 15 5515 5525 10.1158/1078-0432.CCR-05-0464 1:CAS:528: DC%2BD2MXmvFSmur0%3D 16061868
26. RM Prins N Craft KW Bruhn, et al. 2006 The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity J Immunol 176 1 157 164 1:CAS:528:DC%2BD2MXhtlagt7bE 16365406
27. TT Batchelor AG Sorensen E di Tomaso, et al. 2007 AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients Cancer Cell 11 1 83 95 10.1016/j.ccr.2006.11.021 1:CAS:528:DC%2BD2sXhtFClsLc%3D 17222792
28. AA Brandes R Stupp P Hau, et al. 2010 EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma Eur J Cancer 46 2 348 354 10.1016/j.ejca.2009.10.029 1:CAS:528:DC%2BD1MXhs1WgtLfJ 19945857
29. M van den Weller R Stupp G Reifenberger, et al. 2010 MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 6 1 39 51 10.1038/nrneurol.2009.197 1:CAS:528:DC%2BC3cXisV2gtA%3D%3D 19997073
30. MJ van den Bent HJ Dubbink M Sanson, et al. 2009 MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951 J Clin Oncol 27 35 5881 5886 10.1200/JCO.2009.24.1034 19901104
31. FB Furnari T Fenton RM Bachoo, et al. 2007 Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes Dev 21 21 2683 2710 10.1101/gad.1596707 1:CAS:528:DC%2BD2sXhtlSitLrO 17974913
32. R Du KV Lu C Petritsch, et al. 2008 HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion Cancer Cell 13 3 206 220 10.1016/j.ccr.2008.01.034 1:CAS:528:DC%2BD1cXjsVKgs74%3D 18328425
33. AA Brandes E Franceschi A Tosoni, et al. 2008 Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments Clin Cancer Res 14 4 957 960 10.1158/1078-0432.CCR-07-1810 1:CAS:528:DC%2BD1cXhvF2ntL0%3D 18281526
34. KT Kahle D Kozono K Ng, et al. 2010 Functional genomics to explore cancer cell vulnerabilities Neurosurg Focus 28 1 E5 10.3171/2009.10.FOCUS09212 20043720
35. IS Khayal TR McKnight C McGue, et al. 2009 Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas NMR Biomed 22 4 449 455 10.1002/nbm.1357 19125391
36. S Hu M Lustig A Balakrishnan, et al. 2009 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer Magn Reson Med 16 16
37. L Dang DW White S Gross, et al. 2009 Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 462 7274 739 744 10.1038/nature08617 1:CAS:528:DC%2BD1MXhsVGlurzE 19935646